Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

APrevent

Explore full profile

APrevent's products improve voice and communication, focusing on the development of a long- term implant system and speech conversion platform for patients with glottic insufficiency and dysarthria

Stadt Feldkirch, AustriaFounded 2013Health
Valuation $25–50M Last recorded · 2024
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for APrevent and the history behind them.

About APrevent

APrevent Medical Inc. is a medical device company that develops solutions for voice and speech disorders. The company's main product is the APrevent Vocal Implant System (VOIS), a long-term implant for patients with glottic insufficiency and unilateral vocal fold paralysis (UVFP). This system is used in a type I thyroplasty procedure to improve vocal fold function.

The VOIS implant has an adjustable cushion that can be modified both during and after surgery, which allows for a standardized surgical procedure. In addition to the implant, APrevent offers Software-as-a-Service (SaaS) technologies to support voice and speech disorder treatments. The company's business model is focused on providing these specialized medical devices and software to ear, nose, and throat (ENT) specialists and hospitals.

APrevent operates in the medical technology market, with a specific focus on the niche of laryngology and voice-related treatments. The company generates revenue through the sale of its VOIS implants and associated software services. APrevent has a presence in both Asia and Europe, with offices in Taiwan and Austria, indicating a strategy for global market penetration.

Source: Dealroom company data

At a glance

Founded
2013
Headquarters
Stadt Feldkirch, Austria
Sector
Health

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Taiwania Capital
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇹🇼 Taiwan100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about APrevent on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See APrevent on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.